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Human adenocarcinoma (AC) is the most frequently diagnosed human lung cancer and its absolute 
incidence is increasing dramatically. Our study aimed to interpret the mechanisms of human 
adenocarcinoma through the regulation network based on differentially expressed genes (DEGs). We 
used the GSE2514 microarray data to identify human adenocarcinoma differentially expressed genes. 
Based on these genes and collected regulation datasets, 129 relationships between transcription factor 
and their target genes were established in AC. Finally, we find some new candidates and relationships, 
such as IL6 and NFKB1 owning a close connection with AC. Based on a relatively small number of 
patients, the results will need to be repeated and confirmed in future studies. 
 





Lung carcinomas are usually classified as small-cell lung 
carcinomas (SCLC) or non-small-cell lung carcinomas 
(NSCLC). NSCLC is histopathologically and clinically 
distinct from SCLC and is further subcategorized as 
adenocarcinomas, squamous cell carcinomas and large-
cell carcinomas, of which adenocarcinomas are the most 
common (Travis et al.,1995).  
DNA microarray analysis as a global approach is 
applied to investigate physiological mechanisms in health 
and disease (Spies et al., 2002). A high-throughput 
microarray experiment was designed to analyze genetic 
expression patterns and identify potential genes to target 
for AC (Li et al., 2006). Genomic expression profiling 
evolves as a useful tool to identify novel patho-
mechanisms in human cancer (Guo, 2003). These 
differentially expressed genes found from the expression 








may potentially serve as biomarkers in both diagnosis 
and prognosis of human lung cancer (McDoniels-Silvers 
et al., 2002; Dong et al., 2011). The development of 
microarray methods for large-scale analysis of gene 
expression (Chee et al., 1996) makes it possible to 
search  systematically  for  molecular  markers  of  cancer 
classification and outcome prediction in a variety of tumor 
types (Khan et al., 2001). 
The purpose of this study was to propose the hypo-
thesis that a transcriptome network can be developed so 
that a set of transcription factors which regulate the 
differently expression genes play an important role in 
which the progress of AC can be identified.  
 
 




Affymetrix microarray data 
 
One transcription profiles of human adenocarcinoma, GSE2514 
(Stearman et al., 2005) were obtained from a public functional 
genomics data repository GEO (http://www.ncbi.nlm.nih.gov/geo/) 





(Affymetrix Human Genome U95 Version 2 Array) (Wachi et al., 
2005). Only 20 AC chips and 19 control chips are useable. Each 
pair of samples represents a single patient with AC. One is derived 
from the cancer cells and the other is from the normal cells. 
All  patients  participating  in  this  study  were  enrolled  in a local  
colorado multiple institutional review board (COMIRB) approved 
protocol for use of remnant tissue with anonymization and analysis 
of specimens and clinical data. All but one of the patients had a 
history of smoking. Patients range in age from 45 to 73 years of 
age. Tumors from five males and five females were used in the 
study. All specimens for microarray analysis were obtained at 
surgery with nine patients undergoing lobectomy and one wedge 
resection. Specimens were examined immediately after removal 
from the patient and grossly visible solid tumor tissue was snap-
frozen for RNA extraction. The tumors were all invasive ACs, but 
five specimens exhibited evidence of bronchoalveolar differentiation 
at the edge of tumor nests. Most tumors were low to intermediate 
grade and low stage, although, two stage III tumors were included 





Kyoto encyclopedia of genes and genomes (KEGG) is a collection 
of online databases dealing with genomes, enzymatic pathways 
and biological chemicals (Kanehisa, 2002). The pathway database 
records networks of molecular interactions in the cells and variants 
of them specific to particular organisms (http://www. 
genome.jp/kegg/). Total 130 pathways, involving 2287 genes, were 





There are approximately 2600 proteins in the human genome that 
contain DNA-binding domains and most of these are presumed to 
function as transcription factors (Wachi et al., 2005). The 
combinatorial use of a subset of the approximately 2000 human 
transcription factors easily accounts for the unique regulation of 
each gene in the human genome during development (Brivanlou 
and Darnell, 2002).  
These transcription factors are grouped into 5 super class 
families, based on the presence of conserved DNA-binding 
domains. TRANSFAC database contains data on transcription 
factors, their experimentally-proven binding sites and regulated 
genes (Wingender, 2008).  
Transcriptional regulatory element database (TRED) has been 
built in response to increasing needs of an integrated repository for 
both cis- and trans- regulatory elements in mammals (Jiang et al., 
2007). TRED did the curation for transcriptional regulation 
information, including transcription factor binding motifs and 
experimental evidence. The curation is currently focusing on target 
genes of 36 cancer-related TF families. 774 pairs of regulatory 
relationship between 219 transcription factors (TFs) and 265 target 
genes were collected from TRANSFAC (http://www.gene-
regulation.com/pub/databases.html). 5722 pairs of regulatory rela-
tionship between 102 transcription factors (TFs) and 2920 target 
genes were collected from TRED (http://rulai.cshl.edu/ TRED/). 
Combined the two regulation datasets, total 6328 regulatory 
relationships between 276 TFs and 3002 target genes were 
collected (Table 1). 
 
 
Different methods used 
 
Differentially expressed genes (DEGs) analysis 
 
For the GSE2514 dataset, the limma method (Smyth, 2004) was 
used to identify DEGs.  The  original  expression  datasets  from  all  




conditions were processed into expression estimates using the 
RMA method with the default settings implemented in Bioconductor 
and then construct the linear model. The DEGs only with the fold 






For demonstrating the potential regulatory relationship, the Pearson 
correlation coefficient (PCC) was calculated for all pair-wise 
comparisons of gene-expression values between TFs and the 
DEGs. The regulatory relationships whose absolute PCC are larger 
than 0.6 were considered as significant.  
 
 
Gene ontology analysis 
 
The BiNGO analysis (Maere, 2005) was used to identify over-
represented GO categories in biological process.  
 
 
Regulation network construction 
 
Using the regulation data that have been collected from 
TRANSFAC database and TRED database, we matched the 
relationships between differentially expressed TFs and its 
differentially expressed target genes. 
Base on the aforementioned two regulation datasets and the 
pathway relationships of the target genes, we build the regulation 
networks by cytoscape (Shannon et al., 2003). Base on the 
significant relationships (PCC > 0.6 or PCC < -0.6) between TFs 
and its target genes, 129 putative regulatory relationships were 
predicted between 41 TFs and 92 target genes. 
 
 
Significance analysis of pathway 
 
We adopted an impact analysis that includes the statistical 
significance of the set of pathway genes but also considers other 
crucial factors such as the magnitude of each gene’s expression 
change, the topology of the signaling pathway, their interactions, etc 
(Draghici et al., 2007). In this model, the impact factor (IF) of a 
pathway Pi is calculated as the sum of two terms: 
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The first term is a probabilistic term that captures the significance of 
the given pathway Pi from the perspective of the set of genes 
contained in it.  
It is obtained by using the hyper geometric model in which pi is 
the probability of obtaining at least the observed number of 
differentially expressed gene, Nde, just by chance (Tavazoie et 
al.,1999; Draghici et al.,2003).  
The second term is a functional term that depends on the identity 
of the specific genes that are differentially expressed as well as on 
the interactions described by the pathway (that is, its topology).  
The second term sums up the absolute values of the perturbation 
factors (PFs) for all genes g on the given pathway Pi.  
The PF of a gene g is calculated as follows: 
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Table1. Regulation data form TRANSFAC and TRED. 
 
Source Regulation TFs Target Link 
TRANSFAC  774 219 265 http://www.gene-regulation.com/pub/databases.html 
TRED 5722 102 2920 http://rulai.cshl.edu/TRED/ 




In this equation, the first term ΔE (g) captures the quantitative 
information measured in the gene expression experiment. The 
factor ΔE (g) represents the normalized measured expression 
change of the gene g. The first term ΔE (g) in the above equation is 
a sum of all PFs of the genes u directly upstream of the target gene  
g, normalized by the number of downstream genes of each such 
gene Nds (u) and weighted by a factor βug, which reflects the type of 
interaction:  βug = 1  for  induction,  βug = −1  for  repression  (KEGG 
supply this information about the type of interaction of two genes in 
the description of the pathway topology). USg is the set of all such 
genes upstream of g. We need to normalize with respect to the size 
of the pathway by dividing the total perturbation by the number of 
differentially expressed genes on the given pathway, Nde (Pi). In 
order to make the IFs as independent as possible from the 
technology and also comparable between problems, we also divide 
the second term in equation 1 by the mean absolute fold change 
ΔE, calculated across all differentially expressed genes. The result 
of the significance analysis of pathway was shown in Table 3. 
 
 
Regulation network between TFs and pathways  
 
To further investigate the regulatory relationships between TFs and 
pathways, we mapped DEGs to pathways and got a regulation 





Regulation network construction in human 
adenocarcinoma 
 
We constructed a regulation network of human 
adenocarcinoma between TFs and its target genes 
(Figure 1). In this study, PPARG, ETV4, FLI1 and NFKB1 
with higher degrees form a local network which 
suggested that these TFs may play an important role in 
AC. Besides, the MMP9 was regulated by ERG, FLI1, 
ETV4 and PPARG; the IL6 was regulated by PPARG, 
CEBPD and CEBPB which is also observed in our study. 
 
 
Gene ontology (GO) analysis of the regulation 
network in human adenocarcinoma 
 
Several GO categories were enriched among these 
genes in the regulatory network, including positive 
regulation of cellular process, positive regulation of 
biological process, response to chemical stimulus and 
regulation of cell proliferation and so on (Table 2). 
 
 
Significant pathways in human adenocarcinoma 
 
To  identify  the  relevant  pathways  changed  in  AC,  we 
used a statistical approach on pathway level. Significance 
analysis at single gene level may suffer from the limited 
number of samples and experimental noise that can 
severely limit the power of the chosen statistical test. 
Pathway can provide an alternative way to relax the 
significance threshold applied to single genes and may 
lead to a better biological interpretation. So, we adopted 
a pathway based impact analysis method that contained 
many factor including the statistical significance of the set 
of differentially expressed genes in the pathway, the 
magnitude of each gene’s expression change, the 
topology of the signaling pathway, their interactions and 
so on. The impact analysis method yields many 
significant pathways contained leukocyte transendothelial 
migration, cell adhesion molecules (CAMs), Wnt signaling 
pathway and so on (Table 3). 
 
 
Regulation network of TF-pathway 
 
To further investigate the regulatory relationships 
between TFs and pathways, we mapped DEGs to 
pathways and got a regulation network between TFs and 
pathways (Figure 2). In the network, 35 TFs regulated 94 
pathways. CEBPB, CEBPD, ETV4, PPARG and so on 
were shown as hub nodes linked to lots of AC related 
pathways. EGR1, FLI1and FOS both regulated lots of 
pathway including Wnt signaling pathway, Focal 





From the result of regulation network construction in AC, 
we could found that many TFs and pathways closely 
related with AC have been linked by our method. The 
genes PPARG, ETV4, FLI1 and NFKB1 are shown as 
hub nodes in our transcriptome network and some of 
them were proved related to AC by previous study. The 
PPARG, ETV4, MMP9, KDR and IL1B were high related 
to AC proved by previse study. Some evidence also 
suggests that IL6 and NFKB1 may play important roles to 
response to AC. 
PPARG gene encodes a member of the peroxisome 
proliferator-activated receptor (PPAR) subfamily of 
nuclear receptors. PPARs form heterodimers with retinoid 
X receptors (RXRs) and these heterodimers regulate 
transcription of various genes. PPAR-gamma is a 
regulator of adipocyte differentiation. Published data 
found both mRNA and protein levels of PPAR-gamma in 
esophageal adenocarcinoma samples  were  significantly 




Table 2. GO (Gene oncology) biological process analysis. 
 
GO-ID Object Count p-value corr p-value 
48522 positive regulation of cellular process 70 7.57E-27 1.87E-23 
48518 positive regulation of biological process 71 4.18E-25 5.15E-22 
42221 response to chemical stimulus 58 3.98E-24 3.27E-21 
42127 regulation of cell proliferation 43 2.22E-21 1.37E-18 
10033 response to organic substance 43 5.99E-21 2.96E-18 
51239 regulation of multicellular organismal process 45 3.20E-19 1.31E-16 
50794 regulation of cellular process 106 4.00E-19 1.41E-16 
48513 organ development 57 5.80E-19 1.79E-16 
50793 regulation of developmental process 39 7.42E-19 2.03E-16 











Pathway gene  
in Input (%) 
Corrected gamma  
p-value 
KEGG Leukocyte transendothelial migration 246.32 15.966 2.61E-105 
KEGG Cell adhesion molecules (CAMs) 202.63 14.179 2.03E-86 
KEGG Wnt signaling pathway 39.63 5.263 2.50E-16 
KEGG Adipocytokine signaling pathway 15.68 4.478 2.59E-06 
KEGG TGF-beta signaling pathway 11.47 14.943 1.30E-04 
KEGG Complement and coagulation cascades 11.28 17.391 1.55E-04 
KEGG Focal adhesion 11.01 18.227 1.99E-04 
KEGG ECM-receptor interaction 10.03 23.81 4.87E-04 
KEGG PPAR signaling pathway 8.38 15.714 0.0021442 




higher than normal samples. Increased PPAR-gamma 
expression may play an important role in the 
development and progression from normal cells to 
esophageal adenocarcinoma (Wang et al., 2011). The 
vast majority of colorectal cancer is an adenocarcinoma. 
Ligand activation of PPARgamma in colon cancer cells 
causes a considerable reduction in linear and clonogenic 
growth, increased expression of carcinoembryonic 
antigen and the reversal of many gene expression events 
specifically associated with colon cancer. These results 
indicate that the growth and differentiation of colon 
cancer cells can be modulated through PPARgamma 
(Sarraf et al., 1998). 
ETV4 is an ets-oncogene family transcription factor. 
ETV4 was shown to upregulate multiple matrix metallo-
proteinase (MMP) genes and contribute to the malignant 
phenotype of cancer cells by inducing invasive and 
metastatic activities (Shindoh et al., 2004). Previous 
research showed that the ERK-ETV4-MMP-1 axis is 
upregulated in oesophageal adenocarcinoma cells and is 
a potentially important driver of the metastatic pro-
gression of  oesophageal  adenocarcinomas  (Keld et al., 
2010). Further research also found that expression of 
MMP-1 and matrilysin correlated significantly with E1AF 
expression in human colorectal cancer. The results of this 
study suggest that E1AF plays a key role in the 
progression of colorectal cancer (Horiuchi et al., 2003). 
E2F4 gene encodes a protein of the E2F family of 
transcription factors. The E2F family plays a crucial role 
in the control of cell cycle and action of tumor suppressor 
proteins and is also a target of the transforming proteins 
of small DNA tumor viruses. Examination of patients with 
human colon cancer found that expression of E2F4 was 
upregulated and the cell apoptosis was suppressed. 
These data suggest that E2F-4 gene overexpression 
plays a role in the development of colorectal tumors 
(Mady et al., 2002). The mutations of the serine (AGC) 13 
repeats within the E2F-4 gene were found only in the 
squamous cell carcinoma, whereas such alterations were 
not detected in any of the adenocarcinomatous. This 
suggests that E2F-4 might be implicated in the trans-
formation of adenocarcinoma into squamous cell 
carcinoma, though, the underlying mechanism needs to 
be studied (Woo et al., 2000). 











MYC encoded a multifunctional nuclear phosphor-
proteinthat plays a role in cell cycle progression, 
apoptosis and cellular  transformation.  It  functions  as  a  
transcription factor that regulates transcription of specific 
target genes. Myc-associated protein with JmjC domain 
(MAPJD) is a novel member of the MYC transcriptional 
complex and its activation is a common feature of lung 
cancer, selective suppression of this pathway could be a 
promising therapeutic target for treatment of lung cancers 
(Suzuki et al., 2007). Altered apoptotic balance happened 
in the pathogenesis of human adenocarcinomas and 
MYC family genes might affect oncogenesis through 
distinct sets of targets, in particular implicating the impor-
tance of transcriptional repression (Kim et al., 2006). 
MMP9 belongs to the matrix metalloproteinase (MMP) 
family which are involved in the breakdown of 
extracellular matrix in normal physiological processes, 

















































































































tissue remodeling, as well as in disease processes, such 
as arthritis and metastasis. The ischemia-reperfusion 
(I/R) injury incurred during liver surgery can lead to 
cellular dysfunction and elevations in proinflammatory 
cytokines and matrix metalloproteinases. Previous study 
found that hepatic I/R-induced elevations in MMP9 
contribute to the growth of metastatic colorectal 
carcinoma in the liver and that postresection MMP9 
inhibition may be clinically beneficial in preventing 
recurrence following hepatic surgery (Nicoud et al., 
2007). MMP family including MMP9 may be relevant with 
carcinogenesis, development and metastasis of adenoid 
cystic carcinoma. Furthermore, MMP9 would be required 
in the initial steps of invadopodia formation (Nascimento 
et al., 2010). 
KDR (VERFR2) encodes one of the two receptors of 
the VEGF which is a major growth factor for endothelial 
cells. It functions as the main mediator  of  VEGF-induced 
endothelial proliferation, survival, migration, tubular 
morphogenesis and sprouting. Based on analysis of 
salivary adenoid cystic carcinoma (SACC) patients, 
positive correlation between expression of VEGFR2 and 
nerve invasion and vessel metastasis of SACC was 
found. This indicates that VEGFR2 play important roles in 
the invasion and metastasis of SACC (Nong et al., 2010). 
VEGFR2 showed a higher expression level in metastasis 
than primary tumors of medullary thyroid carcinoma. This 
indicated the activation of VEGFR2 may play an 
important role in metastasis of medullary thyroid 
carcinoma (Rodriguez-Antona et al., 2010). 
IL1B encodes a protein of the interleukin 1 cytokine 
family. This cytokine is produced by activated 
macrophages as a proprotein, which is proteolytically 
processed to its active form by caspase 1 (CASP1/ICE). 
This cytokine is an important mediator of the inflam-




















































































































































































































































activities, including cell proliferation, differentiation, and 
apoptosis.   IL-1B   is   a  potent  inhibitor  of  gastric  acid 
secretion. Studies suggest that it is a key determinant in 
gastric adenocarcinoma. Furthermore, IL-1B promoter 
variants T31C and C511T, contribute to the risk of 
developing gastric cancer based on the investigation both 
Chinese and Japanese population (Yang et al., 2004; 
Ikehara et al., 2006). Advanced studies also proved an 
association of 1L1B gene polymorphisms at the two sites 
with lung cancer risk. Patients who have homozygote 
genotypes were more likely to have a mutation in the p53 
gene which is common in many cancers (Zienolddiny et 
al., 2004). 
IL6 encodes a cytokine that functions in inflammation 
and the maturation of B cells. IL6 protein is primarily 
produced at sites of acute and chronic inflammation, 
where it is secreted into the serum and induces a 
transcriptional inflammatory response through its 
receptor. Mutant EGFR could activate the gp130/JAK/ 
STAT3 pathway by means of IL-6 upregulation in primary 
human lung adenocarcinomas. In addition, reduction of 
IL-6 levels by RNA interference led to a decrease in 
tumorigenesis. All those make this pathway a potential 
target for cancer treatment (Gao et al., 2007). 
NFKB1 is a transcription regulator that is activated by 
various intra- and extra-cellular stimuli such as cytokines, 
oxidant-free radicals, ultraviolet irradiation, and bacterial 
or viral products. Activated NFKB translocates into the 
nucleus and stimulates the expression of genes involved 
in a wide variety of biological functions. Analysis of 
several pancreatic ductal adenocarcinoma cell lines 
displayed dramatically elevated levels of subsets of the 
non-canonical NFkappaB target genes CCL19, CCL21, 
CXCL12, CXCL13 and BAFF. This demonstrates that the 
non-canonical NFkappaB pathway is constitutively active 
and functional in pancreatic cancer cells (Wharry et al., 
2009). 
From the result of regulation network between TFs and 
pathways in OA, we could found that there are many 
pathways such as Leukocyte transendothelial migration, 
Wnt signaling, which are closely related with OA have 
been linked by our method.  
Leukocyte transendothelial migration is the pathway 
that leukocyte migrate from the blood into tissues. This 
process is vital for immune surveillance and 
inflammation. During this diapedesis of leukocytes, the 
leukocytes bind to endothelial cell adhesion molecules 
(CAM) and then migrate across the vascular 
endothelium. In endometrioid adenocarcinoma, activated 
leukocyte cell adhesion molecule (ALCAM) expression 
was significantly increased in high-grade tumors and 
cases with myometrial invasion (Liang et al., 2011). In 
pancreatic ductal adenocarcinoma (PDAC), the 
expression of ALCAM is also altered and its serum levels 
are increased. In vitro, ALCAM silencing using RNAi had 
no effects on growth or invasion of pancreatic cancer 





resistance (Hong et  al., 2010).  All those studies proved 
leukocyte   migration   involved   in   the   development  of 
different adenocarcinomas. 
Wnt signaling play a key role in the developmental and 
homeostatic processes including stem cell maintenance, 
growth and cell fate specification, cell polarity and 
migration. In the Wnt/β-catenin cascade, it’s mainly 
means the regulation of ubiquitin-mediated degradation 
of the crucial transcriptional regulator β-catenin (Tauriello 
and Maurice, 2010). Activation of Wnt/β-catenin signaling 
resulted in mouse prostatic intraepithelial neoplasia 
(mPIN). Furthermore, the activation of both SV40-large T-
antigen (Tag) and the Wnt/β-catenin pathway resulted in 
invasive prostate adenocarcinoma. This indicates that 
Wnt/β-catenin signaling has an important role in the 
progression of prostate adenocarcinoma (Yu et al., 2010). 
Wnt-antagonist Dickkopf gene (DKK) 3 involved in 
embryonic development through its inhibition of the WNT 
signaling pathway. Knockdown of DKK3 expression by 
DKK3 SiRNA transfection led to the detachment of lung 
adenocarcinoma cells from the bottom of the culture plate 
and caused apoptosis (Jung et al., 2010). 
Adipocytokine signaling pathway may play an important 
role in OA. Resistin levels were significantly higher in 
colon cancer patients while leptin serum levels were 
significantly lower as compared to controls. Leptin levels 
decreased gradually with tumor stage and aggressive-
ness. Taken together, these results of this study suggest 
that adipokines, in particular resistin and leptin may be 
involved in development and progression of colon cancer 
(Salageanu et al., 2010). Adipo-R1 and Adipo-R2 are two 
receptors of adiponectin (ApN) which is a 30 kDa 
adipocytokine. Adipo-R1 and Adipo-R2 immuno-
expression was only found in gastric cancer and in 
intestinal metaplasia areas near the tumours, but not in 
normal tissues (Barresi et al., 2009). In addition, the two 
receptors Adipo-R1 and Adipo-R2 of ApN also have been 
reported in colorectal cancer tissue and cell line, and the 
expression of ApN was highly associated with the 
colorectal tumors (Barresi et al., 2009). Therefore, further 
studies of the roles adipocytokine played in different 
adenocarcinomas may be beneficial for anticancer 
therapies. 
The basic understanding of the mechanisms underlying 
AC is important. A deeper understanding of transcription 
factors and their regulated genes remain an area of 
intense research activity in futures. Our regulation 
network is useful in investigating the complex interacting 
mechanisms of transcription factors and their regulated 
genes. However, further experiments are still needed to 
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